Prevalence and Spectrum of Non-Motor Symptoms in Patients of Spinocerebellar Ataxias in Kashmiri Population

Bashir A Sanaie; Sajad A Tak; Tanveer Hassan; Ruqia Quansar; Sheikh H Ahmad; Atif R Kawoosa

doi:10.55489/njmr.160420261294

Authors

Bashir A Sanaie Department of Neurology, Government Super Speciality Hospital, GMC, Srinagar, J&K, India
Sajad A Tak Department of Neurology, Government Super Speciality Hospital, GMC, Srinagar, J&K, India
Tanveer Hassan Department of Neurology, Government Super Speciality Hospital, GMC, Srinagar, J&K, India https://orcid.org/0000-0002-3983-5617
Ruqia Quansar Department of Social and Preventive Medicine, GMC Srinagar, Srinagar, J&K, India
Sheikh H Ahmad Department of Neurology, Government Super Speciality Hospital, GMC, Srinagar, J&K, India
Atif R Kawoosa Department of Neurology, Government Super Speciality Hospital, GMC, Srinagar, J&K, India

DOI:

https://doi.org/10.55489/njmr.160420261294

Keywords:

Ataxia, REM sleep behaviour disorder, Anxiety, Depression, Fatigue

Abstract

Background: Spinocerebellar ataxias (SCAs) are progressive neurodegenerative disorders increasingly recognized to have substantial non-motor manifestations. Data regarding these symptoms in the Kashmiri population remain limited.

Objective: To assess the prevalence and pattern of non-motor symptoms among genetically confirmed SCA patients and compare them with healthy controls.

Methods: This observational cross-sectional study was conducted from December 2021 to December 2023 at the Government Super Speciality Hospital, Srinagar. Twenty-five clinically and genetically confirmed SCA patients and 26 age- and sex-matched healthy controls were included. Anxiety, depression, fatigue, sleep disturbances, pain, and cognition were assessed using validated questionnaires. Disease severity was assessed using the Scale for Assessment and Rating of Ataxia (SARA). Data were analyzed using the Mann-Whitney test, with p≤0.05 considered statistically significant.

Results: Among 25 patients, SCA1 was the most common subtype (52%), followed by SCA2 (40%). The median SARA score was 12 (5-37). Compared with controls, SCA patients had significantly higher median scores for anxiety, depression, fatigue, REM sleep behavior disorder, daytime sleepiness, and pain, and significantly lower MMSE scores (all p<0.05), except for restless legs syndrome. Fatigue was significantly greater in SCA2 than SCA1 (median FSS 4.0 vs. 2.7; p=0.005). Pain was reported by 19 patients.

Conclusion: Non-motor symptoms are common among genetically confirmed SCA patients and represent an important component of disease burden. Routine assessment and early management of these manifestations should complement evaluation of motor symptoms.

References

1. Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5(1):24. DOI: https://doi.org/10.1038/s41572-019-0074-3 PMid:30975995

2. Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174-183. DOI: https://doi.org/10.1159/000358801 PMid:24603320

3. Velázquez-Pérez L, Medrano-Montero J, Rodríguez-Labrada R, Canales-Ochoa N, Campins Alí J, Carrillo Rodes FJ, et al. Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients. Cerebellum. 2020 Apr;19(2):252-264. DOI: https://doi.org/10.1007/s12311-020-01107-9 PMid:31981095

4. Van Prooije T, Ibrahim NM, Azmin S, Van De Warrenburg B. Spinocerebellar ataxias in Asia: Prevalence, phenotypes and management. Parkinsonism & Related Disorders. 2021;92:112-118. DOI: https://doi.org/10.1016/j.parkreldis.2021.10.023 PMid:34711523

5. Sharma P, Sonakar AK, Tyagi N, Suroliya V, Kumar M, Kutum R, et al. Genetics of Ataxias in Indian Population: A Collative Insight from a Common Genetic Screening Tool. Adv Genet (Hoboken). 2022;3(2):2100078. DOI: https://doi.org/10.1002/ggn2.202100078 PMid:36618024 PMCid:PMC9744545

6. Jacobi H, Faber J, Timmann D, Klockgether T. Update cerebellum and cognition. J Neurol. 2021;268(10):3921-3925. DOI: https://doi.org/10.1007/s00415-021-10486-w PMid:33656586 PMCid:PMC8463403

7. Mastammanavar VS, Kamble N, Yadav R, Netravathi M, Jain S, Kumar K, et al. Non-motor symptoms in patients with autosomal-dominant spinocerebellar ataxia. Acta Neurol Scand. 2020;142(4):368-376. DOI: https://doi.org/10.1111/ane.13318 PMid:32677041

8. Miller F, Zohar S, Stallard N, Madan J, Posch M, Hee S W, et al. Approaches to sample size calculation for clinical trials in rare diseases. Pharm Stat. 2018;17(3):214-230. DOI: https://doi.org/10.1002/pst.1848 PMid:29322632

9. Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Int J Methods Psychiatr Res. 2010;19(4):223-232. DOI: https://doi.org/10.1002/mpr.323 PMid:20718076 PMCid:PMC6878292

10. Yusuf M, Abera M, Getnet M, Dawud B. Psychometric properties of Hamilton Depression Rating Scale among people with epilepsy in Jimma University Medical Center, Neurology Clinic, Southwest Ethiopia, 2020: cross-sectional study. BMJ Open. 2023 May 30;13(5):e070835. DOI: https://doi.org/10.1136/bmjopen-2022-070835 PMid:37253503 PMCid:PMC10255031

11. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. DOI: https://doi.org/10.1136/jnnp.23.1.56 PMID: 14399272 PMCID: PMC495331

12. Pena-Pereira MA, Sobreira-Neto MA, Sobreira E, Chagas MHN, Oliveira DS, Rodrigues GR, et al. Validation of the Brazilian Portuguese version of the REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ-BR). Arq Neuropsiquiatr. 2020;78(10):629-637. DOI: https://doi.org/10.1590/0004-282x20200125 PMid:33146233

13. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-132. DOI: https://doi.org/10.1016/S1389-9457(02)00258-7 PMid:14592342

14. Walker NA, Sunderram J, Zhang P, Lu S, Scharfet MT. Clinical utility of the Epworth Sleepiness Scale. Sleep Breath. 2020;24(4):1759-1765. DOI: https://doi.org/10.1007/s11325-020-02015-2 PMid:31938991

15. Kendzerska T, Smith PM, Brignardello-Petersen R, Leung RS, Tomlinson G. Evaluation of the measurement properties of the Epworth Sleepiness Scale: a systematic review. Sleep Med Rev. 2014;18(4):321-331. DOI: https://doi.org/10.1016/j.smrv.2013.08.002 PMid:24135493

16. Siciliano M, Chiorri C, De Micco R, Russo A, Tedeschi G, Trojano L, et al. Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach. Parkinsonism Relat Disord. 2019 Aug;65:105-110. DOI: https://doi.org/10.1016/j.parkreldis.2019.05.028 PMid:31147224

17. Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci. 2013;331(1-2):102-107. DOI: https://doi.org/10.1016/j.jns.2013.05.023 PMid:23791482

18. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129-138. PMID: 8080219.

19. Argyropoulos GPD, van Dun K, Adamaszek M, Leggio M, Manto M, Masciullo M. The cerebellar cognitive affective/Schmahmann syndrome: A task force paper. Cerebellum. 2020;19(1):102-125. DOI: https://doi.org/10.1007/s12311-019-01068-8 PMid:31522332 PMCid:PMC6978293

20. Jekpoo S, Wongpakaran N, Wongpakaran T, Wantaneeyawong C, Wiriyacosol P, Methapatara P. Depression and associated factors among patients with spinocerebellar ataxia. Medicina (Kaunas). 2025;61(1):160. DOI: https://doi.org/10.3390/medicina61010160 PMid:39859142 PMCid:PMC11767047

21. Rudolph S, Badura A, Lutzu S, Pathak SS, Thieme A, Verpeut JL, et al. Cognitive-Affective Functions of the Cerebellum. J Neurosci. 2023 Nov 8;43(45):7554-7564. DOI: https://doi.org/10.1523/JNEUROSCI.1451-23.2023 PMid:37940582 PMCid:PMC10634583

22. Yuan X, Ou R, Hou Y, Chen X, Cao B, Hu X, et al. Extra-cerebellar signs and non-motor features in Chinese patients with spinocerebellar ataxia type 3. Front Neurol. 2019;10:110. DOI: https://doi.org/10.3389/fneur.2019.00110 PMid:30833927 PMCid:PMC6388540

23. Brusse E, Brusse-Keizer MGJ, Duivenvoorden HJ, van Swieten JC. Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom. Neurology. 2011;76(11):953-959. DOI: https://doi.org/10.1212/WNL.0b013e31821043a4 PMid:21403106 PMCid:PMC3059136

24. França MC Jr, D'Abreu A, Nucci A, Lopes-Cendes I, Cendes F. Electrophysiological abnormalities in spinocerebellar ataxias: a systematic review. Clin Neurophysiol. 2020;131(6):1400-1410. DOI: https://doi.org/10.1016/j.clinph.2020.02.020 PMid:32304847